ANDA 78388, held by Chartwell Rx. Donepezil Hydrochloride.
As of Nov 16, 2026, ANDA 78388 (Donepezil Hydrochloride), held by Chartwell Rx, was first approved by FDA on Nov 26, 2010, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 26, 2010 | Original application | Approved |
| Donepezil Hydrochloride10MG · tablet, orally disintegrating;oral | Donepezil Hydrochloride | Discontinued |
| Donepezil Hydrochloride5MG · tablet, orally disintegrating;oral | Donepezil Hydrochloride | Discontinued |
| Apr 29, 2011 | Supplement 1Labeling | Approved | None posted |
| Nov 26, 2010 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters